Eli Lilly launches $3.2B tender offer for Morphic

Eli Lilly said on Monday that it will start a tender offer to acquire biopharmaceutical company Morphic for $57 per share in cash, or approximately $3.2 billion.Morphic is a biopharmaceutical company…